Abstract
To estimate the efficacy of screening on colorectal cancer mortality, a population-based case–control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer diagnosed in 1988–94 was compared with screening in controls matched with the case for age, sex and place of residence. Cases were less likely to have been screened than controls, with an odds ratio (OR) of 0.67 [95% confidence interval (CI) 0.48–0.94]. The negative overall association did not differ by gender or by anatomical location. The odds ratio of death from colorectal cancer was 0.64 (95% CI 0.46–0.91) for those screened within 3 years of case diagnosis compared with those not screened. It was 1.14 (95% CI 0.50–2.63) for those screened more than 3 years before case diagnosis. There was a negative association between the risk of death from colorectal cancer and the number of participations in the screening campaigns. The inverse association between screening for faecal occult blood and fatal colorectal cancer suggests that screening can reduce colorectal cancer mortality. This report further supports recommendations for population-based mass screening with faecal occult blood test. © 1999 Cancer Research Campaign
Keywords: colorectal cancer, case–control study, screening, faecal occult blood test
Full Text
The Full Text of this article is available as a PDF (57.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
- Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
- Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
- Newcomb P. A., Norfleet R. G., Storer B. E., Surawicz T. S., Marcus P. M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992 Oct 21;84(20):1572–1575. doi: 10.1093/jnci/84.20.1572. [DOI] [PubMed] [Google Scholar]
- Saito H., Soma Y., Koeda J., Wada T., Kawaguchi H., Sobue T., Aisawa T., Yoshida Y. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer. 1995 May 16;61(4):465–469. doi: 10.1002/ijc.2910610406. [DOI] [PubMed] [Google Scholar]
- Tazi M. A., Faivre J., Dassonville F., Lamour J., Milan C., Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen. 1997;4(3):147–151. doi: 10.1177/096914139700400307. [DOI] [PubMed] [Google Scholar]
- Thomas W. M., Pye G., Hardcastle J. D., Walker A. R. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult. Br J Surg. 1992 Aug;79(8):833–835. doi: 10.1002/bjs.1800790842. [DOI] [PubMed] [Google Scholar]
- Wahrendorf J., Robra B. P., Wiebelt H., Oberhausen R., Weiland M., Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev. 1993 May;2(3):221–227. [PubMed] [Google Scholar]
- Zappa M., Castiglione G., Grazzini G., Falini P., Giorgi D., Paci E., Ciatto S. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer. 1997 Oct 9;73(2):208–210. doi: 10.1002/(sici)1097-0215(19971009)73:2<208::aid-ijc8>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]